As an upstream regulator of NF-κB, a transcription factor that regulates multiple aspects of innate and adaptive immune reactions, the increased availability of PKC-β in diabetic animals has been shown to account for vascular inflammatory response and accelerated atherosclerosis (Kong et al. 2013; Lutzny et al. 2013). Here, NFKB1 is linked to atherosclerosis.